HAVN Life Sciences Inc.

CSE: HAVN, 5NP.F

Company Logo

Company Overview

Havn Life Sciences is a biotechnology company on a mission to unlock human potential using evidence-informed research. The company is focused on standardized, quality-controlled extraction of psychoactive compounds from plants and fungi, and the development of natural health care products from non-regulated compounds. 

Financial Highlights

$0

Revenue (ttm)

$0

Gross Profit (ttm)

-$0.16

Diluted EPS (ttm)

Management Team

Mr. Tim Moore
CEO & Director

Mr. Eli Seamus-Sweet Dusenbury C.A., CPA, CPA, CA
Consultant

Mr. Gordon Clissold FCPA, FCGA
Chief Financial Officer

Ms. Jenna Pozar
Chief Operating Officer

Ms. Susan Chapelle
Exec. Vice-Pres of R&D

Mr. Gary Joseph Leong
Chief Science Officer

Dr. Ivan Casselman
Chief Psychedelics Officer

Mr. Alexzander Samuelsson
Chief Research Officer

Sign Up for Alerts

Receive an email alert every time a company announces a merger, capital raise or files for an IPO.

Company Profile

Website

Twitter

Presentation

Key Highlights

Market Capitalization
$22,537,828

Shares Outstanding
66,771,000

Shares Short (% of Float)
308,458 (0%)

Insider Ownership
1%